New
HealthMore in Health →
Germany’s Planned Healthcare Cuts Draw Early Pushback From Novartis
Novartis chief executive Vas Narasimhan says the company is very disappointed by Germany’s plan to cut more than €60 billion in healthcare costs, setting up an early clash over the consequences for drug sales and market
Key Takeaways
- Germany plans to cut more than €60 billion in healthcare costs.
- Novartis CEO Vas Narasimhan said the company is very disappointed.
DE
DT Editorial AI··via endpoints.news